HI
ANIK icon

Harbour Investments’s Anika Therapeutics ANIK Stock Holding History

Harbour Investments’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-200
Closed -$2.9K – 4777
2026
Q1 		$2.9K Buy
+200
New +$2.32K ﹤0.01% 3788
2021
Q4 		– Sell
-200
Closed -$9K – 2650
2021
Q3 		$9K Hold
200
– – ﹤0.01% 2702
2021
Q2 		$9K Hold
200
– – ﹤0.01% 2779
2021
Q1 		$8K Buy
+200
New +$7.59K ﹤0.01% 2697

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return

Harbour Investments's ANIK Position: Q2 2026 in Review

Harbour Investments sold out of Anika Therapeutics (ANIK) in Q2 2026, closing a stake of 200 shares — an estimated $2.9K sold.

Harbour Investments first reported a position in ANIK in Q1 2021 and held it in 4 quarters. The position peaked at $9K in Q3 2021. 133 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.

  • Harbour Investments reported no remaining Anika Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Harbour Investments sold 200 Anika Therapeutics shares in Q2 2026, an estimated $2.9K.
  • Harbour Investments first reported a position in Anika Therapeutics in Q1 2021 and held it in 4 quarters.
  • Harbour Investments's Anika Therapeutics position peaked at $9K in Q3 2021.
  • 133 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.